Mycoplasma Testing Market Worth to Reach USD 1247.17 million By 2027
Posted On June 21, 2021
The Global Mycoplasma Testing Market report evaluates the market revenue to reach USD 1247.17 million mark in 2027. The CAGR is expected to be close to 10% from 2021 till the end of 2027 according to the newly published report by Value Market Research. Increased demand for fast, accurate, and affordable testing methods is the fundamental market driver responsible for steer the growth of mycoplasma testing. Also, the increasing cell culture contamination is further responsible for the market growth of mycoplasma testing. Increased government initiatives and high funding for research activities will also boost the market growth. Moreover, enhanced market strategies like new product launches, collaborations, partnerships, etc will further drive the market growth of mycoplasma testing. However, mycoplasma detection processes are long and laborious that may hinder the market growth. But the advancements in technology and high spending on research and development activities are expected to propel the market growth of the mycoplasma testing market.
A group of tests that involves measurement of antibodies in the blood produced in response to mycoplasma infection and also detect the presence of microbe by detecting its genetic material in the sample or by cell culture method. Mycoplasma contamination testing must be done at various phases of product development including raw material, viral seed stock, and final product, etc. The cell culture method is the traditional method and the indicator cell culture method, qPCR method are also testing methods that are used for mycoplasma testing. Usually, it requires at least three to six days to get the results of tests and it is advised to take these tests at least once in two months.
The market dynamics covered in the report "Global Mycoplasma Testing Market Report By Product (Assays, Kits, & Reagents, NAT Assays, Kits, & Reagents, ELISA Assays, Kits, & Reagents, Elimination Kits, Stains, Other Assays, Kits, & Reagents, Instruments, Services), By Technology (CR, ELISA, Direct Assay, Indirect Assay, Microbial Culture Techniques, Enzymatic Methods), By End-User (Academic Research Institutes, Cell Banks, Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2021-2027" gives a holistic scope of the market along with the market forecasts.
On the basis of product the market is segmented into Assays, Kits, & Reagents, NAT Assays, Kits, & Reagents, ELISA Assays, Kits, & Reagents, Elimination Kits, Stains, Other Assays, Kits, & Reagents, Instruments, Services. By technology the mycoplasma testing market is categorised as PCR, ELISA, Direct Assay, Indirect Assay, Microbial Culture Techniques, Enzymatic Methods. By end-user the mycoplasma testing market is categorised as Academic Research Institutes, Cell Banks, Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Others. Geographically the research study provides data on North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions. Each region is segregated into North America (North America, United State and Rest of North America), Europe (United Kingdom, France, Germany, and Rest of Europe), Asia Pacific (China, Japan, India, Rest of Asia Pacific), Latin America (Brazil, Rest of Latin America) and Middle East & Africa. This section provides the estimates of market by segment. This section provides the estimates of market by segment thus, providing valuable data to take strategic decisions.
The Report Segments Global Mycoplasma Testing Market -
- Assays, Kits, & Reagents
- NAT Assays, Kits, & Reagents
- ELISA Assays, Kits, & Reagents
- Elimination Kits
- Other Assays, Kits, & Reagents
- Direct Assay
- Indirect Assay
- Microbial Culture Techniques
- Enzymatic Methods
- Academic Research Institutes
- Cell Banks
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Players Profiled In the Report:
Bionique Testing Laboratories, Inc., Biological Industries Israel Beit Haemek Ltd, Lonza Group Ltd., PromoCell GmbH, Merck KGaA, ATCC (American Type Culture Collection), Thermo Fisher Scientific, Charles River Laboratories International, Inc., and InvivoGen.
Download the FREE SAMPLE of Global Mycoplasma Testing Market Research Report
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Email: [email protected]